ARS Pharmaceuticals (SPRY) Share-based Compensation (2020 - 2026)
ARS Pharmaceuticals' Share-based Compensation came in at $12.4 million for Q2 2026, up 130.8% from $5.37 million a year earlier and up 67.0% from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) Share-based Compensation (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, ARS Pharmaceuticals reported Share-based Compensation of $31.24 million, up 68.7% year-over-year; for FY2025, it was $22.1 million, up 52.0% from FY2024.
- Share-based Compensation has increased in each of the last five years, with a five-year compound annual growth rate of 52.9% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $14.53 million in FY2024 (+57.4%), $9.24 million in FY2023 (+58.1%), $5.84 million in FY2022 (+106.5%) and $2.83 million in FY2021 (+7.2%).
- The Q2 2026 figure represents the highest quarterly Share-based Compensation in data going back to Q1 2020.
- Year-over-year, Share-based Compensation has increased for ten consecutive quarters, with growth averaging 63.5% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q1 2023 (growth of 752.3%), and the weakest in Q1 2022 (a decline of 93.8%).
- Business Quant data shows SPRY's Share-based Compensation at $7.42 million (Q1 2026), $5.74 million (Q4 2025) and $5.69 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | ARS Pharmaceuticals | 410.68 Mn | 266.88 Mn | 20.81 Mn | 12.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.40 Mn |
| Mar 31, 2026 | 7.42 Mn |
| Dec 31, 2025 | 5.74 Mn |
| Sep 30, 2025 | 5.69 Mn |
| Jun 30, 2025 | 5.37 Mn |
| Mar 31, 2025 | 5.30 Mn |
| Dec 31, 2024 | 4.26 Mn |
| Sep 30, 2024 | 3.59 Mn |
| Jun 30, 2024 | 3.37 Mn |
| Mar 31, 2024 | 3.32 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 2.10 Mn |
| Mar 31, 2023 | 2.25 Mn |
| Dec 31, 2022 | 4.76 Mn |
| Sep 30, 2022 | 460,000.00 |
| Jun 30, 2022 | 356,000.00 |
| Mar 31, 2022 | 264,000.00 |
| Dec 31, 2021 | -11.21 Mn |
| Sep 30, 2021 | 5.02 Mn |
API Access
ARS Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();